31 August 2026 Appendix 4E - Results for Announcement to the Mark et Provided below are the Results for Announcement to the Market in accordance with ASX Listing Rule 4.3A and Appendix 4E for EVE Health Group and its controlled entities for the financial year ended 30 June 2026 (the...
Appendix 4E
Filed with ASX · · 1 page · English
On 6ix: 6ix.com/news/appendix-4e-307
Release
EVE Health Group Limited on 6ix
Earlier from EVE Health
- Quarterly Activities/Appendix 4C Cash Flow Report - Amended
- Quarterly Activities/Appendix 4C Cash Flow Report
- Eve Initiates Pilot Clinical Study for Libbo ED Film
- Appointment of Chief Executive Officer
- Investor Presentation
Later from EVE Health
- Annual Report to shareholders
- Appendix 4G and Corporate Governance Statement
- Release of Securities from Escrow
- Coffee Microcaps Conference Presentation
- Date of AGM
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health